Home
About Us
Company Culture
Milestones
Awards and Honors
Social Responsibility
Talent Development
Research and Innovation
R&D Team
R&D Management
Pipelines
Innovation Achievements
Product Category
Drug Products
Mipeginterferon Alfa-2b
Telpegfilgrastim Injection
Molgramostim
Filgrastim
Oprelvekin
API
Reagents
Growth Factors
Interleukins
Interferons
Enzymes
Others
News
Contact Us
English
简体中文
Home
/
News
News and Events
Counselor of the State Council and former deputy director of NDRC Hu Zucai and his delegation visit Amoytop.
2023-10-19
Amoytop's Quality Center awarded CNAS certificate
2023-09-15
Launch of New Product-Pegneugen (Telpegfilgrastim Injection)
2023-07-01
New LOGO Comes on Stage: Amoytop Biotech Improves Its Brand Image.
2023-06-12
1
2
3
4
...
8
»
Facebook
Twitter
LinkedIn
Instagram
WELCOME
Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
Fax: +86-592-6889110
international@amoytop.com
Tel: +86-592-6889106
Copyright ©
2023
Amoytop Biotech All Rights Reserved. Support by
Leadong
｜
Sitemap
.
Privacy Policy
Email
international@amoytop.com
reagent@amoytop.com
Tel
+86-592-6889106
cell Phone
+86-18060918257
Leave a Message
Get In Touch
Submit
